Back
NeuroBo Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
NRBO
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
20
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.30
Seasonality Move:
-8.74%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.NeuroBo Pharmaceuticals Price Quote
$2.30
-0.09 (-3.77%)
(Updated: November 15, 2024 at 11:20 AM ET)
NeuroBo Pharmaceuticals Key Stats
Sell
20
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Day range:
$2.39 - $2.60
52-week range:
$2.08 - $6.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.59%
Volume:
55.2K
Avg. volume:
38.2K
1-year change:
-30.6%
Market cap:
$20.6M
Revenue:
$0
EPS:
$-4.77
How Much Does NeuroBo Pharmaceuticals Make?
Data Unavailable
Is NeuroBo Pharmaceuticals Growing As A Company?
Data Unavailable
NeuroBo Pharmaceuticals Stock Price Performance
-
Did NeuroBo Pharmaceuticals Stock Go Up Last Month?
NeuroBo Pharmaceuticals share price went down by -5.91% last month -
Did NRBO's Share Price Rise Over The Last Year?
NRBO share price fell by -30.6% over the past 1 year
What Is NeuroBo Pharmaceuticals 52-Week High & Low?
-
What Is NeuroBo Pharmaceuticals’s 52-Week High Share Price?
NeuroBo Pharmaceuticals has traded as high as $6.75 over the past 52 weeks -
What Is NeuroBo Pharmaceuticals’s 52-Week Low Share Price?
NeuroBo Pharmaceuticals has traded as low as $2.08 over the past 52 weeks
NeuroBo Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NeuroBo Pharmaceuticals?
-
How Much Debt Does NeuroBo Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does NeuroBo Pharmaceuticals Have?
Cash and short term investments quarterly total is $21.7M -
What Is NeuroBo Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.50
Is NeuroBo Pharmaceuticals Cash Flow Positive?
-
What Is NRBO Cash Flow From Operations?
Cash flow from operations (TTM) is -$22.7M -
What Is NeuroBo Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $18.5M -
What Is NeuroBo Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$17K
NeuroBo Pharmaceuticals Return On Invested Capital
Data Unavailable
NeuroBo Pharmaceuticals Earnings Date & Stock Price
-
What Is NeuroBo Pharmaceuticals's Stock Price Today?
A single share of NRBO can be purchased today for 2.39 -
What Is NeuroBo Pharmaceuticals’s Stock Symbol?
NeuroBo Pharmaceuticals trades on the nasdaq under the ticker symbol: NRBO -
When Is NeuroBo Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NeuroBo Pharmaceuticals is scheduled on May 9, 2025 -
When Is NRBO's next ex-dividend date?
NeuroBo Pharmaceuticals's next ex-dividend date is November 15, 2024 -
How To Buy NeuroBo Pharmaceuticals Stock?
You can buy NeuroBo Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NeuroBo Pharmaceuticals Competitors
-
Who Are NeuroBo Pharmaceuticals's Competitors?
Below is a list of companies who compete with NeuroBo Pharmaceuticals or are related in some way:
NeuroBo Pharmaceuticals Dividend Yield
-
What Is NRBO Dividend Yield?
NeuroBo Pharmaceuticals’s dividend yield currently is 0% -
What Is NeuroBo Pharmaceuticals’s Payout Ratio?
NeuroBo Pharmaceuticals’s payout ratio is 0% -
When Did NeuroBo Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is NeuroBo Pharmaceuticals’s Dividend Per Share?
NeuroBo Pharmaceuticals pays a dividend of $0.00 per share
NeuroBo Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 26.67 |
Upside from Last Price: | 1015.76% |